Craft

Fosun Pharma

Stock Price

$1.8

2024-10-29

Market Capitalization

$8.8 B

2024-10-29

Revenue

¥28.4 B

FY, 2019

Fosun Pharma Summary

Company Summary

Overview
Fosun Pharma (also known as Shanghai Fosun Pharmaceutical, 复星医药) is a healthcare group operating in a variety of healthcare sectors including pharmaceutical research, development, and manufacturing, healthcare services, medical diagnosis and devices, as well as pharmaceutical distribution and retail. It offers cardiovascular products, blood system therapeutics, metabolism and alimentary system therapeutics, anti-infection products, anti-tumor therapeutics, and more. The company develops, manufactures, imports, exports, and sells medical equipment and devices, provides healthcare, hospital management, and consulting services, etc.
Type
Public
Status
Active
Founded
1994
HQ
Shanghai, CN | view all locations
Website
https://www.fosunpharma.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Wu Yifang

    Wu Yifang, Executive Director, Chairman and Chief Executive Officer

    • Chen Qiyu

      Chen Qiyu, Executive Director, Co-CEO of Fosun International

    • Dong Xiaoxian

      Dong Xiaoxian, Vice President , Secretary of the Board of Directors and Director of the Secretarial Office

    • Hu Hang

    LocationsView all

    1 location detected

    • Shanghai, Shanghai Shi HQ

      China

      No. 1289, Yishan Road, Building A, Fosun Science Park

    Fosun Pharma Financials

    Summary Financials

    Revenue (H1, 2020)
    ¥14.0B
    Gross profit (H1, 2020)
    ¥7.7B
    Net income (H1, 2020)
    ¥1.9B
    Cash (Q3, 2020)
    ¥9.0B
    Enterprise value
    $24.7B

    Footer menu